Going Nuclear: The Role of XPO1 in Multiple Myeloma

Join myeloma experts Dr. Paul Richardson, Dr. Joe Mikhael, and Dr. Sundar Jagganath for a discussion of recent advances in patient care. You will learn how inhibiting a key protein, XPO1, is impacting the current treatment paradigm.